Candida and human disease

European Annals of Allergy and Clinical Immunology

Volumn 36, Issue 8, 2004, Pages 291-296

  Palma Carlos, A G ^a   Palma Carlos, M L ^a  

^a Clin Allergy and Immunology Center

Author keywords

Allergy; Candida; Candidiasis

Indexed keywords

AMPHOTERICIN B; ANTINUCLEAR ANTIBODY; FLUCONAZOLE; FUNGUS ANTIBODY; FUNGUS VACCINE; ITRACONAZOLE; TERBINAFINE;

ANTIBIOTIC THERAPY; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KEFYR; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA PSEUDOTROPICALIS; CANDIDA TROPICALIS; CANDIDIASIS; CELLULAR IMMUNITY; DEVICE REMOVAL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFECTION RISK; LATEX AGGLUTINATION TEST; MUCOCUTANEOUS CANDIDIASIS; RESPIRATORY TRACT ALLERGY; REVIEW; SPECIES DIFFERENCE; THRUSH; THYROID DISEASE; URINARY TRACT INFECTION; URTICARIA; VAGINA CANDIDIASIS;

ANTIBODIES, FUNGAL; ANTIFUNGAL AGENTS; AUTOIMMUNE DISEASES; CANDIDA; CANDIDIASIS; DISEASE SUSCEPTIBILITY; ENDOCRINE SYSTEM DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOTHERAPY; OPPORTUNISTIC INFECTIONS; ORGAN SPECIFICITY; SPECIES SPECIFICITY;

EID: 8844253022     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. American Society of Clinical Immunology (1994). - Recommendations for the use of hematopoietic colony stimulating factors: evidence based, clinical practice guidelines. J Clin Oncol 12:2471-2508.
2. Appleton S.-S. (2000). - Candidiasis: Pathogenesis, clinical characteristics and treatment. J Calif Dent Ass 28:942-948.
3. Ashman R.-B. (1998). - Candidiasis albicans - pathogenesis, immunity and host defense. Res Immunol 149:281-298.
4. Benett J.-E. (2001). - Candidiasis. In: Braunwald E., Fauci A.-S., Kasper D.-L., Hauser S.-L., Longo D.-L., Jameson J.-L. (eds.) Harrison's Principles of Internal Medicine New York: McGraw-Hill pp 1176-1178.
5. Brunet J.-L., Peyramond D., Cozon GJN. (2001). - Diagnosis of normal and abnormal. Delayed type hypersensitivity to Candida albicans - detection of specific activation. In flow cytometry. Allergie Immunologie 33:115-125.
6. Bryant N.-J. (1992). - Laboratory Immunology and Serology, 3rd edition. Philadelphia: WB Saunders Company pp 307-308.
7. Cook N. (1996). - Serodiagnosis of fungal infections. In Stevens CDS. ed. Clinical Immunology and Serology. Philadelphia Davis, pp. 299-306.
8. Cutler J.-E. (1998). - The Candida albicans phosphomannan complex in Candida host interaction. Res Immunol. 149:299-305.
9. De Sousa M., Cochran R., Macki G.-R., Parrot D., Arala-Chaves M. (1976). - Chronic mucocutaneous candidiasis treated with transfer factor. Br J Dermatol 94:79-88.
10. Dhivert H. (1988). - Desensibilisation au Candida albicans in J. Bousquet, ed. Desensibilization Spécifique. Paris: Masson, pp. 135-140.
11. Edwards J.-E. (1995). - Candida species in Mondell G.-L., Benett E. and Dolin R. eds. Principles and practice of infectious diseases. New York: Churchill Livingstone pp. 2289-2295.
12. Ellis D.-H. (1994). - Clinical mycology. Underdale Australia: Gillingham Printers. Girard J.-P. and Gumovski P. (1985). Chronic asthma due to Candida albicans. Ann. Allergy 55:280-285.
13. Ellis D.-H. (1994). - Clinical mycology. Underdale Australia: Gillingham Printers. Girard J.-P. and Gumovski P. (1985). Chronic asthma due to Candida albicans. Ann. Allergy 55:280-285.
14. Groll A., Walsh T.-J. (1998). - Pharmacology of antifungal compounds. Adv Pharmacol 44:343-500.
15. Groll A.-H., Walsh T.-H. (2001). - Caspofugin: pharmacology, safety and therapeutic potential in superficial invasive fungal infections. Expert Opin Invest Drug 10:1545-1548.
16. Guduri S., Ballas Z.-K. (2002). - Deficient NK-cell function in adult patient with recurrent Non-invasive mucosal candidiasis. J Allergy Clin Immun 109:S186.
17. Hoang A. (2001). - Caspofungin-acetate: an antifungal agent. Am J. Health Syst. Pharm. 58:1206-1214.
18. Huang, Johansson SGO., Zargari A. (1995). - Allergen cross reactivity between Pytyrosporium orbiculare and Candida albicans. Allergy 50:648-656.
19. I.U.I.S. Scientific Committee (1999). - Primary Immunodeficiency diseases. Clin Exp Immunol 118 suppl 1:1-34.
20. James and Warin R.-P. (1971). - An assessment of the role of Candida albicans on food yeasts in chronic urticaria. Br J Derm 84:227-237.
21. Keating G.-M., Jarvis B. (2001). - Caspofungin Drugs 61:1121-1129.
22. Kirkpatrick C.-H. (1989). - Chronic mucocutaneous candidiasis. J Clin Microb Infect Dis 8:448-451.
23. Kirkpatrick C.-H. (2001). - Chronic mucocutaneous candidiasis. Pediatr Infect Dis 20:17-206.
24. Klepser M.-E., Lewis R.-E., Pfaller M.-A. (1998). - Therapy of Candida infections: Susceptibility testing, resistance and therapeutic options. Ann Pharmacotherapy 32:1353-1361.
25. Koivikko A., Kalimok, E., Nieminen E, Savolainen J., Viiljanen M., Viander M. (1998). - Allergenic cross reactivity of yeasts. Allergy 43:192-200.
26. Kontoyiannis D.-P., Luna M.-A., Samuels B.-I., Bodey G.-P. (2000). - Candidiasis. Infect Dis Clin North Am 14:721-739.
27. Kozel T.-H. (1998). - Complement activation by pathogenic fungi. Res Immunol 149:281-289.
28. Lehman P.-F. (1993). - Immunity to fungi. In: Lachmann P.-J., Peters K., Rosen F.-S., Walport M.-D. and Lehner T. (eds). Clinical Aspects of Immunology. Oxford: Blackwell Scientific.
29. Lehner T., Buckley H.-E., Murray G. (1990). - The relationship between fluorescent agglutinating and precipitating antibodies to Candida albicans and their immunoglobulin classes. J Clin Pathol 25:344-352.
30. Lehner T. (1993). - Immunological aspects or oral disease. In: Lachman P.-J., Peters, Rosen F.-S. and Walport M.-J., eds. Clinical aspects of Immunology. Blackwell Scientific: Oxford pp 2027-2077.
31. Lewis R.-E., Klepser M.-E. (1999). - The changing face of nosocomial Candidemia: Epidemiology resistance and drug therapy. Ann J Health Syst Pharm 56:525-533.
32. Mathews R., Burnie J. (1998). - The role of antibodies in protection against candidiasis. Res Immunol 149:343-351.
33. Monteiro F., Loja, Cavalcanti C. (1996). - Investigação e tratamento de vulvovaginitis recurrente por Cândida. Rev Brás Alerg Imunopatologia 16:99-155-156.
34. Moraes PSA. (1993). - Candidiase vaginal de repetição. Rev Bras Alerg Immunopat 16:155-156.
35. Moraes PSA., Lima-Goiaba S., Taketomi E.-A. (2000). - Candida albicans allergen immunotherapy in recurrent vaginal candidiasis. J Invest Allerg Clin Immunol 10:305-309.
36. Moraes PSA., Taketomi E.-A. (2000). - Allergic vulvovaginitis. Ann Allergy Asthma Immunol 85:253-267.
37. Nyirjesry P. (2001). - Chronic vulvovaginal candidiasis. Am Farm Physician 15:697-702.
38. Palma-Carlos A.-G., Palma-Carlos M.-L. (1991). - Incidence of primary and acquired immunodeficiencies in an out-patient population. In: Chapel H.-M., Levinsky R.-J., and Webster ADB. (eds). Progress in Immune deficiency III. London: Royal Society of Medicine pp. 98-100.
39. Palma-Carlos A.-G., Palma-Carlos (2001). - Chronic mucocutaneous candidiasis revisited. Allergie Immunologie 33:229-232.
40. Palma-Carlos A.-G., Palma-Carlos M.-L. (2004). - Candidiasis. In Mycology Handbook of Fungal Biotechnology 493-503. Arora D. K. ed. Marcel Dekker in New York, Basel.
41. Rex J.-H., Walsh T.-J., Sobel J.-D., Filler S.-G., Pappas P.-G., Dismukes W.-E., Edward J.-E. (2000). - Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662-678.
42. Rivas V., Rogers T.-J. (1983). - Studies on the cellular nature of Candida albicans induced suppression. J. Immunol. 130:376-38.
43. Rigg D., Miller M., Metzger J. (1990). - Recurrent vaginal candidiasis: Treatment with Candida allergen immunotherapy. Am J Obs Gynecol 162:331-336.
44. Rosedale N., Brown K. (1979). - Hyposensitization in management of recurring vaginal candidiasis. Ann. Allergy 43:250-253.
45. Savolainen J., Kortekans, Savolainen O., Nermes M. (1998). - IgE, IgA and IgG responses ta common yeasts in atopic patients. Allergy 53:506-512.
46. Savolainen J., Lamminta K., Kalino K., Viander M (1993). Candida albicans and atopic dermatitis. Clin Exp Allergy 23:332-339.
47. Sayag J. (1992). - Allergie fungique. In: Charpin J. and Vervloet D. eds. Paris: Flammarion, Médicine-Sciences, pp. 03-816.
48. Sclafer J., Thibault M. (1986). - Allergie Mycosique. In: Charpin J. (ed) Allergologie. Paris, Flammarion p. 721-730.
49. Schorling S.-R., Kortinga H.-C., Froscyb M., Muhlschegel F-A. (2000). - The role of Candida dubliniensis in oral candidiasis. Gut Rev Microbiol 26:59-68.
50. Segura T., Ballas Z.-K. (1998). - Natural Killer (NK) cell deficiency in a patient with chronic mucocutaneous candiadiasis. J Allerg. Clin Immun 105: suppl, S 74.
51. Shoham S., Levitz S.-M. (2000). - Immune response to fungi. In: Rich R., Fleischer T.-A., Shearer W.-T, Kotzin B.-L., Schroeder H.-W. eds. Clinical Immunology London: Mosby, pp 311-317.
52. Singh N. (2001). - Changing spectrum of invasive candidiasis and its therapeutic implications. Clin Microbiol Infect 7, supp 2, 1-7.
53. Sobel J.-D., Far O.-S., Force R.-W. (1998). - Vulvovaginal candidiasis: epidemiological, diagnostic and therapeutic considerations. Am J Obst Gynec 178:23-11.
54. Sobel J.-D. (2000). - Practide guidelines for the treatment of fungal infections. Clin Infect Dis 30:62-661.
55. Song Y-H., Li Y, MacLaren N.-K. (1998). - Adrenal autoimmunity and the auto- immune polyglandular syndrome type I-III. In: Rose N, and Mackay T. Autoimmune diseases. San Diego, Academic Press, pp 725-736.
56. Yarrow D., Meyer S.-A. (1998). - Proposal for the amendment of the diagnosis of the Genus Candida, Int J Syst Bacteriol 2:611-615.
57. Wey S.-B., Mori M., Pfaller M.-A., Woolson R.-F, Wenzel R.-P. (1998). - Hospital acquired Candidemia. The attribuable mortality and excess lenght of stay. Arch Intern Med 148:2642-2645.